文献速递重症综合管理与镇静镇痛

成人ICU谵妄亚型的发生率与患病率:系统评价与Meta分析

Incidence and Prevalence of Delirium Subtypes in an Adult ICU: A Systematic Review and Meta-Analysis.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论ICU谵妄总患病率31%,其中低活动型最常见(患病率17%、发生率11%),疾病更重或机械通气患者低活动型患病率更高(29%、35%)。

该系统评价与Meta分析检索MEDLINE、EMBASE、CINAHL、SCOPUS、Web of Science和PsycINFO数据库(自建库至2017年10月22日,无限制),纳入48项在成人ICU开展、报告谵妄亚型发生率或患病率的研究(27,342例患者,其中4,550例谵妄)。总患病率为31%(95%CI 24-41;I²=99%)。亚型发生率:高活动型4%、低活动型11%、混合型7%;亚型患病率:高活动型4%、低活动型17%、混合型10%。疾病严重程度高或100%机械通气人群中低活动型患病率更高(分别为29%和35%)。作者认为多数ICU谵妄患者为低活动型,对监测、管理和预后有潜在意义。

要点

  • 48项研究、27,342例成人ICU患者中,谵妄总患病率为31%(95%CI 24-41),研究间异质性I²=99%。
  • 低活动型谵妄患病率17%(95%CI 13-22)、发生率11%(95%CI 8-17),高于高活动型(患病率4%、发生率4%)和混合型(患病率10%、发生率7%)。
  • 疾病严重程度高的人群低活动型谵妄患病率为29%(95%CI 18-46),100%机械通气人群为35%(95%CI 23-55),均高于总体低活动型患病率。
  • 作者认为多数ICU谵妄患者为低活动型,这一发现对监测、管理和预后有潜在意义。
  • 研究间存在显著异质性(总患病率I²=99%,各亚型I²在92%-99%之间)。

适用人群与场景

  • 纳入任何内科、外科或专科ICU的成人患者,研究报告了按谵妄亚型分类的发生率或患病率估计。

研究设计与关键结果

  • 系统评价与Meta分析纳入48项研究,共27,342例患者,其中4,550例谵妄,总患病率31%(95%CI 24-41;I²=99%)。
  • 亚型发生率(18项研究):高活动型4%(95%CI 2-6;I²=92%)、低活动型11%(95%CI 8-17;I²=97%)、混合型7%(95%CI 4-11;I²=97%)。
  • 亚型患病率(31项研究):高活动型4%(95%CI 3-6;I²=94%)、低活动型17%(95%CI 13-22;I²=97%)、混合型10%(95%CI 6-16;I²=99%)。
  • 疾病严重程度高的人群低活动型患病率29%(95%CI 18-46;I²=95%),100%机械通气人群低活动型患病率35%(95%CI 23-55;I²=93%),均高于总体低活动型患病率。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,遵循PRISMA标准检索6个数据库(MEDLINE、EMBASE、CINAHL、SCOPUS、Web of Science、PsycINFO),自建库至2017年10月22日,无限制。
  • 局限:研究间存在显著异质性(总患病率I²=99%,各亚型I²在92%-99%之间)。

对床旁实践的改变

  • 作者认为多数ICU谵妄患者为低活动型,这一发现对监测、管理和预后有潜在意义。
  • 低活动型谵妄患病率在不同研究人群中存在差异,疾病严重程度更高的患者中更高(29% vs 总体17%),100%机械通气患者中为35%。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Use systematic review and meta-analytic methodology to estimate the pooled incidence, prevalence, and proportion of delirium cases for each delirium subtype (hypoactive, hyperactive, and mixed) in an adult ICU population.

DATA SOURCES: We conducted a search of the MEDLINE, EMBASE, CINAHL, SCOPUS, Web of Science, and PsycINFO databases following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards from database inception until October 22, 2017, with no restrictions.

STUDY SELECTION: We included original research conducted in adults admitted to any medical, surgical, or speciality ICU that reported incidence or prevalence estimates of delirium according to delirium subtype.

DATA EXTRACTION: Data were extracted on sample size, population demographics, condition information, and reported delirium estimates.

DATA SYNTHESIS: Forty-eight studies (27,342 patients; 4,550 with delirium) with an overall pooled prevalence of 31% (95% CI, 24-41; I = 99%) met inclusion criteria. The pooled incidence (n = 18 studies) of delirium subtypes were hyperactive (4% [95% CI, 2-6]; I = 92%]), hypoactive (11% [95% CI, 8-17; I = 97%]), and mixed (7% [95% CI, 4-11; I = 97%]). The pooled prevalence (n = 31 studies) of delirium subtypes were hyperactive (4% [95% CI, 3-6; I = 94%]), hypoactive (17% [95% CI, 13-22; I = 97%]), and mixed (10% [95% CI, 6-16; I = 99%]). The pooled prevalence of hypoactive delirium in study populations with a similarly high severity of illness or mechanically ventilated was higher (severity of illness: 29% [95% CI, 18-46%; I = 95%], 100% mechanically ventilated: 35% [95% CI, 23-55%; I = 93%]) compared with the pooled prevalence of hypoactive delirium.

CONCLUSIONS: Despite significant heterogeneity between studies, these data show the majority of delirious ICU patients to have hypoactive delirium, a finding with potential monitoring, management, and prognostic implications. The prevalence of hypoactive delirium varies between-study populations and is higher in patients with greater severity of illness.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Krewulak KD, Stelfox HT, Leigh JP, et al. Incidence and Prevalence of Delirium Subtypes in an Adult ICU: A Systematic Review and Meta-Analysis. Crit Care Med. 2018. PMID: 30234569. doi:10.1097/CCM.0000000000003402

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。